TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
3 hedge funds and large institutions have $271K invested in TITAN PHARMACEUTICAL INC in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
47% less capital invested
Capital invested by funds: $508K → $271K (-$237K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
+$7K |
| 2 |
GS
Gagnon Securities
New York
|
+$695 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JIR
James Investment Research
Alpha,
Ohio
|
-$137K |
TTP Hedge Fund Activity: Q3 2014 in Review
3 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q3 2014, worth a combined $271K — down 47% from $508K a quarter earlier.
Fund positioning in TTP was balanced in Q3 2014: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Vantage Investment Advisors, opening a new position worth an estimated $7K. The largest seller was James Investment Research, exiting entirely with an estimated $137K sold.
- 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $271K of TITAN PHARMACEUTICAL INC stock for Q3 2014, down 47% quarter-over-quarter.
- 1 fund opened new TITAN PHARMACEUTICAL INC positions in Q3 2014 and 1 closed out, a net change of 0 holders.
- The largest TITAN PHARMACEUTICAL INC buyer in Q3 2014 was Vantage Investment Advisors, an estimated $7K added.
- The largest TITAN PHARMACEUTICAL INC seller in Q3 2014 was James Investment Research, an estimated $137K sold.
Based on aggregated 13F filings for Q3 2014.